These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12096274)

  • 41. Human models of acute lung injury.
    Proudfoot AG; McAuley DF; Griffiths MJ; Hind M
    Dis Model Mech; 2011 Mar; 4(2):145-53. PubMed ID: 21357760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.
    Shyamsundar M; McKeown ST; O'Kane CM; Craig TR; Brown V; Thickett DR; Matthay MA; Taggart CC; Backman JT; Elborn JS; McAuley DF
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1107-14. PubMed ID: 19324974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical management of small abdominal aortic aneurysms.
    Baxter BT; Terrin MC; Dalman RL
    Circulation; 2008 Apr; 117(14):1883-9. PubMed ID: 18391122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis.
    Guessous I; Periard D; Lorenzetti D; Cornuz J; Ghali WA
    PLoS One; 2008 Mar; 3(3):e1895. PubMed ID: 18365027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.
    Aoki H; Yoshimura K; Matsuzaki M
    J Mol Med (Berl); 2007 Oct; 85(10):1077-88. PubMed ID: 17522832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.
    Aziz F; Kuivaniemi H
    Ann Vasc Surg; 2007 May; 21(3):392-401. PubMed ID: 17484978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathology, natural history and treatment of abdominal aortic aneurysms.
    Zankl AR; Schumacher H; Krumsdorf U; Katus HA; Jahn L; Tiefenbacher CP
    Clin Res Cardiol; 2007 Mar; 96(3):140-51. PubMed ID: 17180573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases.
    Biezeveld MH; van Mierlo G; Lutter R; Kuipers IM; Dekker T; Hack CE; Newburger JW; Kuijpers TW
    Clin Exp Immunol; 2005 Jul; 141(1):183-8. PubMed ID: 15958085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.
    Steinmetz EF; Buckley C; Shames ML; Ennis TL; Vanvickle-Chavez SJ; Mao D; Goeddel LA; Hawkins CJ; Thompson RW
    Ann Surg; 2005 Jan; 241(1):92-101. PubMed ID: 15621996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
    Sinha S; Frishman WH
    J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.
    Nagashima H; Aoka Y; Sakomura Y; Sakuta A; Aomi S; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
    J Vasc Surg; 2002 Jul; 36(1):158-63. PubMed ID: 12096274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms.
    Wilson WR; Evans J; Bell PR; Thompson MM
    Eur J Vasc Endovasc Surg; 2005 Sep; 30(3):259-62. PubMed ID: 16009575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.
    Rahman MN; Khan JA; Mazari FA; Mockford K; McCollum PT; Chetter IC
    Ann Vasc Surg; 2011 Jan; 25(1):32-8. PubMed ID: 20889295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall.
    Nagashima H; Aoka Y; Sakomura Y; Uto K; Sakuta A; Aomi S; Kurosawa H; Hagiwara N; Kawana M; Kasanuki H
    J Vasc Surg; 2004 Feb; 39(2):447-53. PubMed ID: 14743151
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.